L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
ATC group of level 4 – chemical subgroup · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 6 medicines in this group and its subgroups.
- 5 prescription only (POM)
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
-
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
- L01EM01 idelalisib 2 medicines
- L01EM03 alpelisib 3 medicines
- L01EM04 duvelisib 1 medicine
-
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
1 more subgroup has no medicine with a leaflet on this site.
Active substances in the group
- Alpelisib 3 medicines
- Duvelisib 1 medicine
- Idelalisib 2 medicines
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Copiktra 15 mg hard capsules (L01EM04 duvelisib) | – |
| Piqray 150 mg film-coated tablet SPC (L01EM03 alpelisib) | Prescription only (POM) |
| Piqray 200 mg film-coated tablet SPC (L01EM03 alpelisib) | Prescription only (POM) |
| Piqray 50 mg & 200 mg film-coated tablets SPC (L01EM03 alpelisib) | Prescription only (POM) |
| Zydelig 100 mg film-coated tablets SPC (L01EM01 idelalisib) | Prescription only (POM) |
| Zydelig 150 mg film-coated tablets SPC (L01EM01 idelalisib) | Prescription only (POM) |
Other groups of the same level
- L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
- L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 6 medicines
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 14 medicines
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 10 medicines
- L01EF Cyclin-dependent kinase (CDK) inhibitors 13 medicines
- L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 27 medicines
- L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 4 medicines
- L01EJ Janus-associated kinase (JAK) inhibitors 18 medicines
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 12 medicines
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 8 medicines
- L01EX Other protein kinase inhibitors 94 medicines
Other names of the ATC group
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EM
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.